Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
CA LÂM SÀNG Issue: Số 94+95 , 2021 BỆNH TIM BẨM SINH

No translate

Cao Mạnh Hưng: Bác sĩ nội trú, Đại học Y Hà Nội; Nguyễn Thị Duyên: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai; Phạm Bá Nha: Khoa Phụ sản, Bệnh viện Bạch Mai; Trương Thanh Hương: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Published: August 20, 2026
Views: 464
DOI 10.58354/jvc.94.95.2021.173

Abstract

No translate

Keywords
No translate

References

1.
1. Buyon JP, Clancy RM, Fridman DM. Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med. 2009;265:653-62.
DOI: doi.org/10.1111/j.1365-2796.2009.02100.x
2.
2. Buyon JP, Clancy RM, Friedman DM. Cardiac Manifestations of Neonatal Lupus Erythematosus: guidelines to management integrating integrating clues from the bench and bedside. Nat Clin Pract Rheumatol. 2009;5:139–48.
3.
3. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: Mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658–66.
DOI: doi.org/10.1038/ncprheum1018
4.
4. Carolis SD, Salvi S, Botta A et al. Which Intrauterine Treatment for Autoimmune Congenital Heart Block? Open Autoimmunity Journal. 2010;2:1-10.
5.
5. Costedoat-ChalumeauN,AmouraZ,LeThiHong D et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis. 2003;62:1010-2.
DOI: doi.org/10.1016/s0735-1097(98)00161-2
6.
6. Friedman DM, Llanos C, Izmirly PM et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010;62:1138–46.
7.
7. FriedmanDM,KimMY,CopelJAetal. Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block.
8.
8. Ambrosi A, Dzikaite V, Park J, et al. AntiRo52 monoclonal antibodies specific for amino acid 200- 239, but not other Ro52 epitopes, induce congenital heart block in a rat model. Ann Rheumatic Dis 2012;71:448-54.
9.
9. SalomonssonS,SonessonSE,OttossonL,etal. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005;201:11-7.
DOI: doi.org/10.1136/ard.62.10.1010
10.
10. The PR interval and Dexamethasone evaluation (PRIDE) Prospective Study. Circulation. 2008;117:485-93.
11.
11. Gupta M, Hamilton R, Berul C et al. Pediatric congenital atrioventricular block. Medscape, Dec 6, 2011.
DOI: doi.org/10.1016/s8756-5005(10)79327-6
12.
12. Jaeggi ET, Fouron JC, Silverman ED et al. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110:1542-8.
13.
13. Nield LE, Silverman ED, Smallhorn JF et al. Endocardial ← broelastosis associated with maternal anti-Ro and anti La antibodies in the absence of atrioventricular block. Circulation. 2002;40:796–802.
14.
14. Puria S, Pooni P, Mohan B et al. Pregnancy With SLE and Fetal Congenital Heart Block: A Case Report. Cardiol Res. 2013;4:126-8.
DOI: doi.org/10.1136/annrheumdis-2011-200414
15.
15. RosenthalE. Classification of congenital complete heart block: autoantibody-associated or isolated? Lupus. 2003;12:425-6.
No translate

Files

PDF
Article Views464
Document Views0
Downloads5
Section CA LÂM SÀNG
Issue Số 94+95 , 2021
Category BỆNH TIM BẨM SINH
Pages 205-209
Copyright Holder 2021 Tạp chí Tim mạch học Việt Nam

Related articles section label

Related articles

Related articles category hint

More articles

No translate

Congenital heart disease is the most common birth defect, with an estimated prevalence of 8 per 1,000 live births. Advances in diagnosis, surgery, and cardiac intervention (including prenatal) have markedly improved surv...

Chi tiết bài báo
PDF
68
Nguyễn Ngọc Quang; Nguyễn Thị Hải Yến